COMPLETED

Care Transition Intervention for Hospitalized Patients With Advanced Cancer

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study is examining whether a care transition intervention, CONTINUUM (CONTINUity of care Under Management by video visits), consisting of a supportive care-focused video visit with an oncology nurse practitioner (NP) within three business days of hospital discharge, may improve post-discharge transitions of care for recently hospitalized patients with advanced cancer.

Official Title

Randomized Trial of a Care Transition Intervention for Hospitalized Patients With Advanced Cancer

Quick Facts

Study Start:2021-12-15
Study Completion:2025-03-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:COMPLETED

Study ID

NCT05142345

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Age \>= 18 years
  2. * First unplanned admission since diagnosis of advanced cancer to to the oncology service at Massachusetts General Hospital (MGH) or the medicine service with oncology consultation
  3. * Known diagnosis of advanced breast, thoracic, genitourinary, gastrointestinal cancers, sarcoma, or melanoma
  4. * Receiving ongoing oncology care at MGH
  5. * Verbal fluency in English
  6. * Internet/wifi or telephone access
  7. * Residing in Massachusetts at the time of hospital discharge
  1. * Admitted electively
  2. * Discharged to a location other than home or expired during admission
  3. * Discharged with hospice services

Contacts and Locations

Principal Investigator

Daniel E Lage, MD
PRINCIPAL_INVESTIGATOR
Massachusetts General Hospital

Study Locations (Sites)

Massachusetts General Hospital Cancer Center
Boston, Massachusetts, 02114
United States

Collaborators and Investigators

Sponsor: Massachusetts General Hospital

  • Daniel E Lage, MD, PRINCIPAL_INVESTIGATOR, Massachusetts General Hospital

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2021-12-15
Study Completion Date2025-03-30

Study Record Updates

Study Start Date2021-12-15
Study Completion Date2025-03-30

Terms related to this study

Keywords Provided by Researchers

  • Cancer
  • Follow-Up Care
  • Care Services, Home
  • Consultation, Remote
  • Advanced Cancer
  • Hospitalization
  • Care Transition Intervention

Additional Relevant MeSH Terms

  • Cancer
  • Follow-Up Care
  • Consultation, Remote
  • Advanced Cancer